“Response to Singh et al., Dupilumab as a novel therapy for management of delusions of parasitosis: A case series”
Dominique Fontaine, Veronica Voronina, Sarah Gonzalez, Dylan J. Parker, Larissa Pastore, Sivan Rotenberg, Brian J. Rosen, M. Shane Chapman · 2026
Read “Response to Singh et al., Dupilumab as a novel therapy for management of delusions of parasitosis: A case series” by Dominique Fontaine, Veronica Voronina, Sarah Gonzalez, Dylan J. Parker, Larissa Pastore, Sivan Rotenberg, Brian J. Rosen, M. Shane Chapman (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13471348.txt.
Description
Dominique Fontaine and colleagues write in 2026 in response to a case series proposing the antibody drug dupilumab for delusions of parasitosis. In that condition, patients hold a fixed false belief that parasites infest their skin. The problem sits between skin medicine and mental health care. The original series reported partial or limited improvement in nine of eleven patients treated with the drug, which is normally used for allergic skin disease.
The letter engages that claim directly, weighing what such a series can and cannot show. The writers examine the reasoning for choosing an immune targeted drug in a delusion based illness. They also weigh the strength of the reported responses. Their letter keeps the proposal visible while pressing for caution before a mental condition is treated as a skin problem. Readers get both the original claim and a peer critique in one record.
Catalog record
| CREATOR | Dominique Fontaine, Veronica Voronina, Sarah Gonzalez, Dylan J. Parker, Larissa Pastore, Sivan Rotenberg, Brian J. Rosen, M. Shane Chapman |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 7295 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |